SILO - PRICE - Silo Pharma, Inc.

Silo Pharma, Inc. (SILO) price action reflects the business development of a company integrating ESG environmental standards and bioethics into the creation of psychotropic agents. Silo Pharma, Inc. (SILO) focuses on the synthesis of non-hallucinogenic psilocybin microdoses for the therapy of PTSD and chronic pain via virtual R&D. The current indicator stands at 1.75, while the market valuation already prices in pipeline risks and expectations from preclinical tests against fibromyalgia.

The closing price reflects the market consensus on the asset's value, capturing the balance of supply and demand to determine the current market capitalization of the issuer. By analyzing the price trajectory, investors assess the growth potential of Silo Pharma, Inc. (SILO), considering the effectiveness of their R&D strategy, which relies on delegating research to university laboratories to minimize operating expenses and diversify development risks.